Vir Biotechnology to Host a Call on Sotrovimab’s Retained Activity Against the Omicron SARS-CoV-2 Variant

Rhea-AI Summary

Vir Biotechnology announced a conference call on December 7, 2021, at 8:30 am ET, to share new data regarding sotrovimab's effectiveness against the Omicron variant of SARS-CoV-2. The call will highlight how sotrovimab maintains its activity against various mutations in the spike protein of the Omicron variant. Interested participants can join the call via telephone or access a live webcast on the Vir website, where it will also be archived for 30 days.

--Company to Host Conference Call on Tuesday, December 7, 2021, at 8:30 am ET--

SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) announced that Management will host a conference call at 8:30 am ET, Tuesday, December 7, 2021, to discuss new data that demonstrates sotrovimab retains activity against the full combination of mutations in the spike protein of the Omicron SARS-CoV-2 variant.

To access the call via telephone, please dial (833) 727-9519 (North America) or (830) 213-7696 (International), conference ID: 9894016.

A live webcast of the call can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.

About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B virus, influenza A and human immunodeficiency virus. For more information, please visit www.vir.bio.

FAQ

What is the date and time of the Vir Biotechnology conference call?

The Vir Biotechnology conference call is scheduled for December 7, 2021, at 8:30 am ET.

What will be discussed during the Vir conference call?

The conference call will discuss new data showing that sotrovimab retains activity against mutations in the spike protein of the Omicron variant.

How can I access the Vir Biotechnology conference call?

You can access the call by dialing (833) 727-9519 for North America or (830) 213-7696 for international calls, using conference ID: 9894016.

Where can I find the live webcast of the Vir conference call?

The live webcast of the Vir conference call can be accessed in the Events & Presentations section of the Vir website.

How long will the Vir conference call webcast be available?

The webcast of the Vir conference call will be archived on their website for 30 days.